Delivery Order SPE2DB22D1202-SPE2DB25FVDZ9

Award Date 7/7/25
Potential Completion Date 7/8/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,170.24 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALVANCE 500 MG VIALS, a pharmaceutical product, with a completion date of May 28, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $37,270.48 delivery order contract to Amerisourcebergen Drug Corp for the supply of DALVANCE 500 MG VIALS pharmaceutical products. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities from the vendor to support military treatment programs and facilities worldwide....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,445.50, is for the delivery of DALVANCE 500 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of August 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical,...
The U.S. government awarded a $20,890.61 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide DALVANCE 500 MG VIALS medical supplies. This contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a performance period through January 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DALVANCE 500 MG VIALS. The $5,377.68 firm fixed price contract has an ultimate completion date of April 21, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,127.13, is a Firm Fixed Price Delivery Order for the supply of DALVANCE 500 MG VIALS. The contract has an ultimate completion date of April 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,090.15 firm fixed-price delivery order is for the supply of 4,567,894,030 units of DALVANCE 500 MG vials. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $6,474.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALVANCE 500 MG VIALS, a pharmaceutical product, with a completion date of February 19, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $38,705.60 and is for the delivery of DALVANCE 500 MG VIALS, a specialty pharmaceutical product. The contract is a firm fixed-price type with a period of performance through March 25, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568345157 DALVANCE 500 MG VIALS, with a ceiling value of $8,962.70 and a completion date of May 27, 2025. The contract is a firm fixed-price, non-set-aside delivery order. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FVDZ9
    Delivery Order

This is a $2,781.37 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DALVANCE 500 MG VIALS, a pharmaceutical product, with a performance period through July 8, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global pharmaceutical support to military healthcare programs through December 2026. The contract is not designated as a set-aside.

Generated 10/12/25, 12:52 AM